SAN DIEGO, Sept. 1, 2020 /PRNewswire/ — ProSciento, Inc., a leading specialty clinical research organization (CRO) exclusively focused on NASH, diabetes, obesity and related metabolic diseases, today announced the appointment of Stephen Mullennix to the role of Chief Financial Officer (CFO). Mr. Mullennix joins ProSciento with a diverse global finance […]